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ABSTRACT
Genome copy number is an important source of ge-
netic variation in health and disease. In cancer, Copy
Number Alterations (CNAs) can be inferred from
short-read sequencing data, enabling genomics-
based precision oncology. Emerging Nanopore se-
quencing technologies offer the potential for broader
clinical utility, for example in smaller hospitals, due
to lower instrument cost, higher portability, and ease
of use. Nonetheless, Nanopore sequencing devices
are limited in the number of retrievable sequencing
reads/molecules compared to short-read sequenc-
ing platforms, limiting CNA inference accuracy. To
address this limitation, we targeted the sequencing
of short-length DNA molecules loaded at optimized
concentration in an effort to increase sequence
read/molecule yield from a single nanopore run. We
show that short-molecule nanopore sequencing re-
producibly returns high read counts and allows high
quality CNA inference. We demonstrate the clini-
cal relevance of this approach by accurately infer-
ring CNAs in acute myeloid leukemia samples. The
data shows that, compared to traditional approaches
such as chromosome analysis/cytogenetics, short
molecule nanopore sequencing returns more sen-
sitive, accurate copy number information in a cost
effective and expeditious manner, including for mul-
tiplex samples. Our results provide a framework for
short-molecule nanopore sequencing with applica-
tions in research and medicine, which includes but
is not limited to, CNAs.
INTRODUCTION
Copy number variation is a common form of genomic vari-
ation in humans and has been found to be correlated with
a number of pathologies including rare genomic disorders
(1), neurological diseases (2,3) and cancer (4). In cancer,
somatically acquired Copy Number Alterations (hereafter
reference to as CNAs) contribute substantially to the re-
modeling of cancer genomes with diagnostic, prognostic,
and therapeutic implications (5,6). Traditionally, CNA in-
formation has been retrieved via methods such as chromo-
some analysis/karyotyping and DNA-FISH (7), which have
limitations in sensitivity and/or resolution of analysis. Next
generation sequencing addresses these limitations by show-
ing that high resolution CNA information is retrievable
from short-read sequencing data using a variety of experi-
mental and computational approaches (8–13). These efforts
have culminated in the successful implementation of short-
read sequencing in the clinic (14,15). However, such appli-
cations are still associated with substantial costs and have
been largely confined to large, resource rich, clinical centers.
Enabling smaller, community-based centers with the ability
to retrieve cancer sequence information, in a cost-effective
manner, is likely to enhance the quality of health care over-
all.
New technological advances have paved the path for a
newer form of sequencing termed nanopore sequencing
(16,17). Nanopore sequencing relies on the detection of
ionic current fluctuations as DNA molecules translocate
through a protein pore (i.e. nanopore) and the subsequent
transformation of these signals into nucleotide information
(18). Nanopore sequencing offers many advantages com-
pared to traditional short-read sequencing technologies,
including single-molecule detection, portability, and low in-
strument cost as well as the ability to retrieve sequence in-
formation from large contiguous fragments of DNA, i.e.
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long read sequencing (19). Of these advantages, the ability
to sequence long DNA molecules has received the most at-
tention in biomedical research because of its potential to
shed light on complex areas of the genome, such as repet-
itive elements and segmental duplications, areas that re-
main largely unexplored (20). Further, long read nanopore
sequencing has been shown to reveal cryptic genetic vari-
ation that is missed by traditional short-read sequencing
approaches, accentuating the importance of this emerging
sequencing technology in biomedical research and, poten-
tially, clinical practice (21–23).
One major shortcoming of nanopore sequencing has
been the relatively low yield in terms of the number of dis-
tinct sequenced DNA molecules. For example, compared
to an Illumina NextSeq machine run, which typically re-
turns hundreds of millions of short-reads, a standard long
DNA molecule nanopore run on a MinION device yields
an average of approximately one million reads. This limita-
tion has hindered wide-spread utility of nanopore sequenc-
ing in research and clinical sequencing applications that re-
quire high read counts, especially CNA inference. Here, we
apply a simple yet effective experimental approach to ad-
dress this limitation by loading and sequencing relatively
short molecules of DNA and show that it reproducibly re-
turns high read/molecule counts, sufficient for high resolu-
tion CNA analysis using the widely studied SK-BR-3 breast
cancer cell line as well as seven acute myeloid leukemia
(AML) samples. Our approach provides a foundation for
future studies where real-time, point of care sequencing ap-
plications in cancer, and other diseases, can be done with
minimal infrastructure in clinical centers, large and small
alike.
MATERIALS AND METHODS
Samples included in study, DNA extraction, and sequencing
library preparation
To develop the short molecule sequencing approach, we
first experimentally tested DNA library preparation con-
ditions and sequencing on DNA retrieved from a widely
studied breast cancer cell line, SK-BR-3, which we and oth-
ers have used as a reference for CNA method development
(9,24,25). For nanopore sequencing library preparation,
SK-BR-3 cell line DNA was fragmented to ∼500 bp using
the Covaris Instrument (Woburn, MA). 300 ng of sonicated
material was A-tailed and end repaired using the NEB A-
tailing end repair module. Adaptor ligation for nanopore se-
quencing was performed using the SQK-LSK-109 kit from
Oxford Nanopore. Three different DNA library loading
masses were tested to determine optimal loading condition;
15, 45 and 90 ng. 15 ng is equivalent to 50 fmol of ds-
DNA; the maximum, manufacturer suggested mass gDNA
for loading. We hypothesized that a larger mass of DNA
could improve throughput for smaller fragments, thus 45 ng
(3× the suggested molar mass) and 90ng (6x the molar
mass) were also tested. Each aliquot of library was loaded
onto a R9.4.1 MinION flow cell and allowed to run for 48
h on a GridION.
For clinical implementation feasibility studies, we relied
on sequencing DNA retrieved from acute myeloid leukemia
(AML) samples. Five samples were considered for MinION
sequencing, two that were cytogenetically classified as nor-
mal karyotype and three classified as complex karyotype
(CK-AML), with the latter known to confer a dismal prog-
nosis in AML disease. We also sequenced two additional
AML samples, one complex and one normal, using the low
throughput Flongle. DNA was extracted from bone mar-
row leukemic blasts using a Qiagen AllPrep DNA/RNA
Mini Kit following recommended manufacturer’s protocols.
Purified DNA was similarly processed for nanopore se-
quencing as per final experimental conditions established
using SK-BR-3 DNA. For multiplex nanopore sequenc-
ing, DNA was prepared as described above with the fol-
lowing exception: after the initial A-tailing and end re-
pair step, DNA was ligated to a PCR based barcoding
adapter (EXP-PCB096) for unique indexing with a ham-
ming distance of at least 10 between their sequences. The





TCCAGGGTTTGTGTAACCTT. Five barcoded samples
were then pooled in an equimolar fashion, with a total mass
of 300ng between all five samples. The pooled samples were
processed with the SQK-LSK-109 kit. Samples were base
called with the on-board GPU system with Guppy v3.1. The
research involving human subjects, specifically the AML
samples, was approved by the authors Institutional Review
Board (MSKCC IRB).
For each analyzed sample (SK-BR-3 as well as AML
samples), a matching short-read Illumina sequencing li-
brary was constructed and sequenced on a HiSeq device us-
ing standard Illumina protocols (San Diego, CA).
Nanopore sequence read base calling, processing, and analy-
sis
To ascertain an appropriate short DNA molecule length to
sequence on a Nanopore device, we performed an analysis
where long molecule nanopore sequencing data of at least
10 kb were computationally truncated to shorter molecules
that differed by 100 bp, starting from 100 bp and ending
with 1 kb (e.g. 10 different read length classes). All reads
were mapped to the hg38 genome built, excluding alternate
scaffolds. MAPQ is defined as −10 × log10 Pr(alignment is
wrong), and minimap2 reports a maximum MAPQ value
of 60. The reads were partitioned into bins based on read
length, and within each bin we computed the fraction of
unaligned reads, reads with perfect MAPQ, and reads with
sub-optimal MAPQ (Supplemental Figure S1A).
For each sequencing run we computed read length distri-
butions, read counts over time, channel lifetimes, molecule
residence time (i.e. the time duration for an actively se-
quenced read), pore vacancy time (i.e. the time between
reads in a given channel), and channel activity. All summary
statistics provided in Table 1 based on the ‘sequencing sum-
mary’ files output by the Guppy basecaller. These summary
files include the time that each read started and finished se-
quencing, which channel reads came from, read lengths, and
quality scores. Read counts were computed using a simple
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per Channel’ was computed by dividing the reads per chan-
nel by the number of channels on the device (512 for Min-
ION, 126 for Flongle). Channel lifetimes were estimated by
the time that each channel finished sequencing its final read.
The distribution of vacancy time between reads was com-
puted by subtracting the start and end times of consecu-
tive reads, excluding reads which were not sequenced by the
same pore within a channel. The channel activity plots were
generated by dividing each channel into five minute win-
dows and coloring a window black if the channel sequenced
any length of a read during that time.
Copy number inference from short read and short molecule
sequencing data
Nanopore sequencing data was mapped to human reference
genome hg19 using Minimap2 (26) software with the fol-
lowing parameters: -ax map-ont -t 15. Uniquely mapped
reads were subsequently filtered using Samtools (27) with
the following parameters: -Sbu -q 20 -F 0 × 904. Sorted
reads were indexed and counted in genomic bins of median
length of 600 000 and 150 000 kb derived by dividing the
genome into the five thousand (5k) and twenty thousand
(20k) bins respectively, using the Varbin algorithm (25,28).
Normalized bin counts were subsequently segmented using
Circular Binary Segmentation (29) with stringent segmen-
tation requiring five contiguous bins to call a copy number
transition. Thus, at 5k and 20k bin resolutions, the analysis
can segment and detect copy number events at resolutions
of 3 Mb (5 × 600 000 kb) and 0.75 Mb (5 × 150 000 kb). Seg-
mented read count data were subsequently transformed to
absolute copy number values using a least square fitting al-
gorithm (9,24). Short read Illumina sequencing data was se-
quenced at depths comparable to short molecule nanopore
data (median depths of ∼ 8 million total reads per sample)
and processed as previously described (24).
AML sample chromosomal analysis
Fresh bone marrow aspirates were used for conventional
chromosome analysis following standard protocol, with-
out mitogen stimulation in short term culturing. At least
20 metaphase cells were analyzed, and karyotype was de-
scribed according to the international system of human
chromosome nomenclature (7). Independent numerical and
structural chromosomal abnormalities, such as gain, loss,
deletion, addition, duplication, balanced or unbalanced
translocations, inversion and derivative chromosomes, as
well as marker chromosome, ring chromosome were anno-
tated in defining complex karyotypes, i.e. three or more,
clonal heterogeneity, and monosomal karyotype.
DNA-FISH validation of identified copy number alterations
in AML
FISH analysis was performed on bone marrow or pe-
ripheral blood pellets from cytogenetic analysis in selected
samples, following standard protocols. Various commercial
FISH probes, specific for myeloid neoplasia, such as for
deletion or loss of chromosomes 5, 7, 17, gain of chro-
mosome 8, and for MLL/KMT2A (11q23) translocations,
EVI1 (3q26.2), and other translocations, were used as ap-
propriate. All probes were purchased from several compa-
nies, such as Abbott Molecular (Des Plaines, IL), Metasys-
tems (Newton, MA). At least 200 cells were analyzed, and
results were described according to (7). In all samples, cor-
relation of FISH results and chromosome analysis findings
were also compared.
RESULTS
Sequencing short DNA molecules on a nanopore device yields
high read counts and enables accurate copy number profiling
The number of reads/molecules returned in a standard
long read MinION run is limited by (i) the design of the
nanopore array, especially the overall number of channels
and the overall number of active pores; (ii) the molecule ki-
netics of DNA fragments docking to the nanopore, mea-
sured by the duration between the end of one read and the
beginning of the next within the same pore (the vacancy
time) and (iii) the residence time of a molecule translocat-
ing through a given pore. Consequently, we hypothesized
that loading DNA molecules that are shorter in length (e.g.
400 bp in median length compared to a standard 10 kb)
would decrease the residence time of each DNA molecule in
a pore and thus facilitate, over a period of time, the translo-
cation of more DNA molecules and the retrieval of higher
read/molecule counts.
To experimentally test our hypothesis, we sonicated DNA
purified from the SK-BR-3 breast cancer cell line to an aver-
age length of 400 bps and prepared a nanopore sequencing
library using standard protocols (Materials and Methods).
We targeted an average DNA molecule length of 400 bps
in part due the relationship between length and mappabil-
ity of DNA molecules on a nanopore device (Supplemen-
tary Figure S1A, Materials and Methods) and to allow di-
rect comparisons with Illumina sequencing data. For short
read/molecule sequencing on a R9.4.1 MinION flowcell,
we decided to load libraries at concentrations of 1, 3 and
6× the Molar Equivalent (ME) of standard loading con-
ditions (Materials and Methods), henceforth referred to as
Short-1ME, Short-3ME and Short-6ME respectively. Vary-
ing the loading conditions we performed to ascertain the re-
lationship between number of molecules loaded and subse-
quently sequenced in each experiment. As a control, a long
read sequencing library from the same SK-BR-3 DNA was
generated and sequenced using standard protocols (Mate-
rials and Methods).
Sequencing the long molecule nanopore library resulted
in an expected yield of ∼1 million molecules. By con-
trast, loading the Short-1ME sequencing library resulted
in roughly 6 million sequenced molecules, a 6-fold increase
(Figure 1A). Interestingly, while the number of active se-
quencing channels decayed with a similar trend for both se-
quencing conditions (Figure 1B), the increased read yield in
the Short-1ME library was largely attributed to an acceler-
ated return of sequenced molecules over the first 12 hours
(Figure 1A, Supplementary Figure S1B). We attribute the
increase in sequenced molecule return primarily to reduced
residency and vacancy time. Residency time is directly pro-
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Table 1. Annotations and sequencing statistics for samples run on a MinION device













Cancer Cell Line SKBR3 SKBR3-Long 899425 8360.86 84.94 10.17 9295.79 14301 291.93
Cancer Cell Line SKBR3 SKBR3-Short (1ME) 6332668 3024.8 86.42 10.54 477.65 538 16.5
Cancer Cell Line SKBR3 SKBR3-Short (3ME) 1465247 789.33 89.61 10.89 538.7 637 17.07
Cancer Cell Line SKBR3 SKBR3-Short (6ME) 699009 416.13 88.69 10.73 595.32 732 19.35
Leukemia (AML-BM) AML1 3797811 1670.22 84.97 9.09 439.79 501 15.13
Leukemia (AML-BM) AML2 6065542 2510.64 81.17 8.69 413.92 461 16.42
Leukemia (AML-BM) AML3 2312000 1072.69 91.29 9.72 463.96 503 16.59
Leukemia (AML-BM) AML4 3935726 1753.57 86.68 9.29 445.55 488 15.58
Leukemia (AML-BM) AML5 6263490 2886.35 82.82 8.95 460.82 519 15.53
AML = acute myeloid leukemia, ME = molar equivalent.




Figure 1. Sequencing short molecules on a nanopore device yields high read counts and enables accurate copy number profiling. (A) Cumulative number of
reads/molecules sequenced over time throughout each SK-BR-3 nanopore run (ME = molar equivalent). (B) Total number of ‘living’ channels over time
throughout each run as measured by the time that the last read was sequenced by each channel. Note that a channel may not produce a read for several
hours but still be considered ‘alive’ by this definition. (C) Distributions of timing between discrete DNA molecules entry/exit from a given channel, i.e.
vacancy time. (D) Genome-wide copy number profiles of SK-BR-3 sequenced using short molecule nanopore (right panel) and short-read Illumina (left)
data. Profiles are plotted when dividing the genomes in 5 thousand bins (i.e. 5k bins). Examples of detected CNAs are annotated on the profiles.
sequencing, for example ∼1 s for a 400 bp molecule com-
pared to 22 s for a 10 kb molecule when sequencing at 450
bp per second. Further, vacancy time is also shorter when
sequencing short molecules, regardless of loading concen-
tration (Figure 1C). Short-1ME sequencing reads were of
similar quality to long reads when comparing sequencing
metrics such as Pass Filter (86% Short-1ME versus. 85%
Long) and mean Q-Score values (10.54 Short 1ME versus
10.17 Long) (Table 1). The average length of the sequenced
DNA molecules was confirmed to be roughly 500bps (Sup-
plementary Figure S1C).
Importantly, following normalization (Methods and
Supplementary Figure S2), processing of the data for copy
number inference using previously developed algorithms
(9,24) that relate read depth (i.e. molecules sequenced at
a given genome locus) to genome copy number, the data
returned highly accurate copy number information at var-
ious resolutions compared to information retrieved from
standard Illumina short-read sequencing as well as long
molecule nanopore data (Materials and Methods) (Figure
1D and Supplementary Figure S3A). Detected copy num-
ber events ranged in size from a few megabases to whole
chromosome arm and chromosome level events (Figure 1D
and Supplementary Figure S3B). These included: (i) focal
amplifications at the MYC and ERBB2 genes, (ii) gain on
1q and (iii) deletion on 17p, all CNAs of variable sizes
shown to be associated with a poor prognosis across a range
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analysis revealed consistently accurate genome-wide copy
number inference at depths of 2 million, 1 million, and
500 000 reads total, consistent with prior published work.
Downsampling to 250 000 total reads and below frequently
resulted in spurious segments and erroneous copy number
calls (Supplementary Figure S3C).
Short-3ME and Short-6ME libraries yielded 11 and 6
times more sequenced reads respectively relative to long
reads over the first two hours, however the sequencing yield
pattern decayed rapidly (Figure 1A). This pattern was asso-
ciated with a diminishing number of active channels over
time as well as vacancy time relative to the Short-1ME
sequencing experiment (Figure 1A–C). As the quality of
the data is similar to that from long and Short-1ME data
(Table 1, Supplementary Figure S1B), we hypothesize that
this decline may be a consequence of the mechanics of
nanopore/electrical circuitry and/or limiting reagent avail-
ability to drive the translocation of DNA molecules through
the MinION nanopore channels.
Overall, these data show that loading short DNA
molecules, at an appropriate concentration, to a Min-
ION nanopore device can yield up to 6 million sequenced
molecules in a single run, data which can be used to infer
CNAs with high accuracy.
Short molecule sequencing on a MinION device allows ac-
curate, high resolution copy number inference in a clinically
relevant setting
To assess the potential utility of short molecule sequenc-
ing on MinION devices in retrieving clinically actionable
and relevant information, we turned to the analysis of acute
myeloid leukemia (AML) genomes where extensive evi-
dence exists on the prognostic importance of CNAs (i.e.
karyotypes/cytogenetics). Five samples were sequenced,
two that were cytogenetically classified as normal karyotype
and three classified as complex karyotype (CK-AML), with
the latter known to confer a dismal prognosis in AML dis-
ease. All AML samples were sequenced using Short-1ME
loading conditions. In parallel, all samples were sequenced
on an Illumina machine for comparative analysis.
All AML samples sequenced using Short-1ME load-
ing conditions yielded expected high read counts (∼4–6
million reads per sample) (Table 1). Further, all samples
displayed similar high-quality sequencing statistics, such
as Pass Filter and mean Q-Scores, as with the Short1-
ME SK-BR-3 data (Table 1). When processed for copy
number inference, we find that the nanopore Short-1ME
data yields largely similar genome-wide profiles and CNAs
with Pearson correlation coefficients above 0.98 across all
samples when compared to Illumina data (Figure 2A–C
and Supplementary Figure S4). For example, for sample
AML2, nanopore sequence data inferred CNAs that were
highly correlated to those inferred from Illumina sequenc-
ing data (Pearson correlation values > 0.99) with large dele-
tions on chromosomes 5 and 7 (over 10MBs) as well as
complex re-arrangements on chromosome 11 resulting in
MLL1/KMT2A gene gains identified. Further, identified
alterations shared largely identical breakpoint positions in
both datasets (Figure 2B–D). Moreover, focal alterations on
chromosome arms 12p and 16p were also identified in both
nanopore and Illumina sequencing data and corroborated
with standard cytogenetic analysis (Figure 2E and Supple-
mentary Figure S4).
In multiple cases, nanopore sequencing data resulted
in more accurate copy number information compared to
standard cytogenetic chromosome analysis. For example,
in AML5, cytogenetically reported monosomy (i.e. loss of
an entire chromosome) for chromosome 20 was shown in
both Illumina and nanopore sequencing data to be inac-
curate, most likely the result of incorporation of chromo-
some 20 genetic material into marker chromosomes (Fig-
ure 2F). Likewise, copy number analysis at higher resolu-
tion, afforded as a direct consequence of the increased read
counts, identified a focal deletion on the short arm of chro-
mosome 17 (17p) encompassing the TP53 gene in the se-
quencing data (Figure 2F). Selected alterations (MLL and
TP53) were validated using DNA-FISH analysis in their re-
spective samples (Figure 2G).
Together, these results show that short molecule se-
quencing on a MinION device reproducibly yields high
read/molecule counts that are of high quality. Further,
when processed informatically, the data results in highly ac-
curate copy number profiles that are concordant with both
matching Illumina data and standard cytogenetic results.
The data also show that short molecule nanopore sequenc-
ing returns cryptic CNA information that is either missed or
mis-classified in standard cytogenetic, chromosome-based
analyses.
High read counts enable multiplex sequencing and copy num-
ber inference of AML samples on a MinION device
Sequencing-based copy number inference tools can rely on
sparse, low coverage sequencing to relate sequencing depth
in genomic intervals to copy number (9,24). Furthermore,
sequencing depth can be adjusted to accommodate vary-
ing resolution of analysis, typically targeting an average of
30–50 reads per genomic bin for a reliable CNA inference
(9,24). Given the comparatively high number of sequencing
molecules retrieved by sequencing Short-1ME nanopore li-
braries, multiplexing of different samples on the same Min-
ION run is theoretically possible. Multiplexing would lower
the costs associated with retrieving sequencing-based copy
number information as well as provide flexibility in terms
of sample processing, both issues that are relevant from a
clinical implementation perspective. To this end, we gener-
ated uniquely indexed short molecule nanopore sequencing
libraries for all five sequenced AML samples. Indexed AML
samples were subsequently pooled at equal molar concen-
trations and the resulting pool sequenced on a single Min-
ION device run (Materials and Methods).
Pooled AML Nanopore run yielded slightly fewer num-
ber of sequenced molecules compared to previous short
nanopore runs; ∼3.2 million reads. Regardless, the sequenc-
ing data was of high quality (93% passed filter and 11.15
mean Q-score) enabling 91% of the sequenced molecules to
be assigned to a sample barcode (average of ∼600 000 reads
per sample, 18% of total reads per sample) (Supplemen-
tary Figure S5A). When processed for CNA analysis, the
multiplex data generated largely similar genome-wide copy
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Figure 2. Short molecule sequencing on a MinION nanopore device yields accurate high resolution copy number information in a clinically relevant
setting. (A) and (B) Genome-wide copy number profiles of a normal and a complex karyotype sample sequenced using short molecules on a MinION
(lower panel) and short-read on an Illumina instrument (upper panel). (C) Density scatter correlation plot of normalized bin read counts (proportional
to copy number) from MinION and Illumina sequencing data for leukemic sample AML-2. Pearson correlation value is provided. (D) Zoom in views of
chromosome 7 (left panel) with complex rearrangement resulting in loss of both short and long arms and chromosome 11 (right panel) with gains of the
long arm at various level in complex karyotype sample AML-2 using Nanopore (gray line) and Illumina (black line) sequencing data. Dashed gray vertical
lines illustrate alteration breakpoints. (E and F) Zoom in views of chromosomal deletions on chromosomes 12p, 16p, 17p and 20q. Right panel in (F)
illustrates chromosome images derived from cytogenetic analysis showing a normal chromosome 20 (top) and a marker chromosome (bottom) which was
redefined as a derivative chromosome 20 with deletion of the long arm based on this study (G) DNA-FISH based validation of selected CNA alterations.
Gain of the MLL gene on chromosome cytoband 11q23 (top panel), using a break apart MLL probe set (5’MLL and 3’MLL are labeled in orange and
green respectively); two cells (arrows) show five copies of MLL/KMT2A. FISH tests confirm focal 17p loss, encompassing the TP53 gene (bottom panel).
TP53 probe and D17Z1 (CEP17-Cen) probes are labeled in orange and green, respectively. Three cells (arrows) show two green signals for CEP17 and only
one orange signal for TP53. Nuclei are counterstained with DAPI (blue).
non-multiplex data, with Pearson correlation coefficients
above 0.95 (Figure 3A, B and Supplementary Figure S5B–
E). Identified CNAs, which were similarly detected in non-
multiplex nanopore and Illumina sequencing data, included
both deletions as well as gains, either as whole chromosome
or interstitial, focal alterations, with events targeting impor-
tant AML genomic regions such as 5q, 7q and 17p (Fig-
ure 3A, B and Supplementary Figure S5). Events were con-
firmed orthogonally using DNA-FISH experiments (Figure
3C).
Thus, the increase in return in terms of the number
of high quality sequencing molecules afforded by loading
short DNA fragments on a nanopore device facilitates mul-
tiplex sequencing and accurate inference of copy number
information in an affordable and versatile manner.
Short molecule sequencing using a Flongle adaptor yields
high read counts and allows cheap portable sequencing
The MinION device has generally been known as a
single-use nanopore sequencing device. Recently, Oxford
Nanopore introduced the Flongle adaptor; a low-cost re-
placeable apparatus that utilizes similar chemistry in pro-
ducing single molecule sequence data. This, in effect, makes
the MinION device a repeat-use sequencing device. High
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A B
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Figure 3. Increased read counts via short molecule sequencing enables accurate, multiplex profiling on a MinION device. (A) Heatmap illustration of copy
number profiles of all profiled AML samples (n = 5) using Illumina, MinION, and Multiplex MinION sequencing. Annotations regarding karyotype status
of leukemic sample (normal vs. complex) and sequencing modality are denoted on bars on top of the heatmap. Heatmap color and bar color codes are
provided below the heatmap. Selected, prognostically relevant CNAs are identified on heatmap. (B) Genome-wide copy number profiles from a complex
karyotype AML sample inferred from short molecule nanopore sequencing in multiplex (lower panel) and non-multiplex mode (upper-panel). (C) DNA-
FISH based validation of identified copy number alterations on the long arm of chromosomes 5 and 7(Chr5q and Chr7q respectively). A 5p15.2 probe
(labeled in green) and a centromeric probes (D7Z1, CEP7) for chromosome 7 were used as an internal control (Con). Left: two cells (arrow) show two
green signals for 5p and only one orange signal for 5q. Right: all three cells (arrow) show two green signals for CEP7 and only one orange 7q. Color codes
of probes are illustrated. Nuclei are counterstained with DAPI.
Flongle device theoretically can enable the retrieval of clini-
cally actionable CNA data (i.e. karyotypes and CNA infor-
mation) in settings outside large health care centers as well
as countries with poorly developed health care infrastruc-
ture. To assess the feasibility of such applications, we gener-
ated short molecule nanopore libraries for a normal kary-
otype AML case and a complex karyotype AML case and
using a Flongle adaptor for each, sequenced both. Short-
read Illumina sequencing was also performed on DNA
available for both cases.
Similar to short molecule sequencing on a non-Flongle
MinION unit, Flongle based sequencing continued to re-
turn relatively high, short molecule sequence information
over the first 12 h of the sequencing run with diminishing
returns thereafter (Figure 4A and Supplementary Figure
S6A). Short read Flongle runs yielded much lower numbers
of sequenced molecules in terms of absolute counts; ∼600k
and 300k for Flongle runs compared to ∼4–6 million Min-
ION runs (Supplementary Figure S6B). However, when an-
alyzing for number of sequenced molecules while normaliz-
ing for the number of sequencing channels (Flongle con-
tains 126 channels compared to the standard 512 for a non-
Flongle MinION unit), the data illustrate that Flongle short
molecule sequencing returns almost one order of magnitude
more data than a long molecule run (Figure 4B). The pat-
tern of sequenced molecule return was similarly associated
with a shorter vacancy time compared to long molecule se-
quencing, although vacancy time was longer than that ob-
served with non-Flongle MinION Short-1ME runs (Sup-
plementary Figure S6C). While Flongle runs yielded lower
statistics for passed and mean Q-score (Supplementary Fig-
ure S6B), approximately 176 000 and 327 000 reads (83%
and 86% of total pass filter reads) were uniquely mapped,
enough to process for copy number analysis. Analysis of the
Flongle nanopore data revealed that while one sample ex-
hibited a normal copy number profile, the other sample dis-
played a pattern of deletions on chromosomes 1, 8, 9 and
11 resulting in complex karyotype annotations, consistent
with matching cytogenetic data (Figure 4C and D).
Together, the data shows that the Flongle adaptor, when
coupled with short molecule sequencing, is capable of facil-
itating sequencing applications that require a discrete num-
ber of sequenced molecules (ex: copy number profiling at
specific resolutions). Furthermore, given the early stage na-
ture of the Flongle in terms of development, we expect fur-
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Figure 4. Short molecule sequencing using a Flongle adaptor enables high read counts, accurate copy number data, and cheap, portable sequencing.
(A) Absolute number of sequenced molecules for a Flongle run compared to other nanopore runs. Short 1ME and Long are as depicted in Figure 1A.
(B) Normalized number of sequenced molecules per channel for each nanopore run (126 channels for Flongle and 512 channels for MinION). (C and D)
Genome-wide copy number profiles of a complex karyotype (C) and a normal karyotype (D) AML case inferred from short molecule nanopore sequencing
(top-panel) and short read Illumina sequencing (lower panel), respectively.
the context of short molecule sequencing in future itera-
tions, and in doing so, allow higher resolution copy number
analysis.
DISCUSSION
Nanopore single molecule sequencing offers unique ad-
vantages compared to Illumina short read sequencing in-
cluding real-time sequencing, portable sequencing, and the
potential to sequence long molecules of DNA. Numer-
ous studies have now shown the utility of each of the
aforementioned advantages in the rapid re-identification
of human samples, facilitating fast point-of-care diagnos-
tics for infectious diseases, the first complete, telomere-to-
telomere sequence of a human chromosome and several
other applications (30–33). However, an important limi-
tation of nanopore sequencing continues to be the rela-
tively low number of sequencing reads returned per se-
quencing run, regardless of instrument/device (i.e. Min-
ION, GridION or PromethION). This presents challenges
for nanopore sequencing utility in ‘counting’ applications
such as allelic genotyping/single nucleotide discovery and
genome copy number inference, applications that require
high read counts, at specified loci or distributed over a
given genome, respectively. This is important as methods
for the identification of CNAs, particularly hematolog-
ical malignancies, have long been considered important
tests/procedures to perform in the course of the clinical
management of patients (5). Furthermore, increasing evi-
dence has emerged regarding the importance of CNAs in
more common, solid malignancies such as breast and lung
cancer (6,34).
Here, by (i) making a simple optimization with regards
to molecule length when factoring DNA molecule kinetics
during translocation through a nanopore and (ii) applying
an elementary strategy of loading short DNA molecules on
a MinION device, we devise and validate a simple yet effec-
tive solution: short molecule nanopore sequencing. Load-
ing short molecules of DNA (median length of 0.5 kb) on
a MinION device consistently resulted in a 4- to 6-fold in-
crease in the return of sequenced single molecules with the
inferred CNA information concordant with that obtained
from standard short-read Illumina sequencing and at much
higher resolution than clinical karyotyping. Importantly,
the increase in sequence molecule return on a nanopore run
facilitated multiplex sequencing of clinical samples which
decreases costs associated with sequence based copy num-
ber determination/karyotyping. Furthermore, in a multi-
plex sequencing setting, the increase in sequence molecule
counts affords the flexibility to modulate sequence read
counts to accommodate low purity samples or higher res-
olution analysis (e.g. for low purity sample or higher res-
olution analysis, more limited multiplexing and increased
sequencing depths would be more advantageous). While
the utility of Illumina short-read sequencing platform in
retrieving CNA information in a clinical setting is useful
and will garner broad application, our results show that
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provides a complementary platform associated with unique
advantages. For example, CNA information from short
molecule nanopore sequencing can easily be implemented
in outreach clinical settings which are not equipped with Il-
lumina machines and associated infrastructure. Supplemen-
tary Table S1 summarizes the advantages/disadvantages of
both Illumina short-read and nanopore short molecule se-
quence based copy number detection.
The short molecule nanopore sequencing approach pre-
sented here has broad applications in research and clin-
ical practice including, but not limited to, global DNA
modification profiling via shotgun DNA sequencing as well
as multiplex cancer gene amplicon sequencing. Most im-
portantly, we show here that high molecule return on a
nanopore can enable multiplex sequencing, that when cou-
pled with molecular barcoding, vastly decreases the costs
and time associated with the retrieval of clinically important
information, such as karyotype information in AML dis-
ease. Additionally, in relation to sequence associated costs
and potential clinical utility, we present results of short
molecule nanopore sequencing within the context of the
Flongle adaptor, providing further evidence for the po-
tential for cost effective, point-of-care diagnostics using
nanopore sequencing technology in cancer.
While others have devised innovative approaches using
nanopore sequencing to address genomic applications that
require high molecule/read counts (35), our approach is
much simpler, especially for barcoded multiplexed samples.
Hence, we surmise that short molecule nanopore sequenc-
ing is more likely to gain broad applicability and equally
important, empower further technological developments in
the rapidly evolving field of single-molecule sequencing. For
example, we have recently reported on the development of
an algorithm termed UNCALLED for the targeted enrich-
ment of genomic sequences based on analysis of raw elec-
trical nanopore signals and ejection of unwanted molecules
from any given pore (36). Coupling the methods used in
short molecule sequencing with targeted enrichment of spe-
cific loci could enable the retrieval of the entire repertoire
of germline and somatic alterations found in a cancer, in-
cluding single nucleotide variants, insertions and deletions
as well as balanced structural variants all from a single se-
quencing run. Indeed, our early results point towards the
feasibility of such an approach.
In conclusion, we show that short molecule nanopore se-
quencing facilitates increased sequence molecule return, en-
abling applications that require sequencing counts, such as
CNA detection, that are inaccessible with standard, cur-
rent nanopore practices (i.e. long molecule sequencing).
We show that the data is high quality and when applied
to address a biomedical question, such as retrieving clini-
cally meaningful copy number information, returns accu-
rate data at low costs and much flexibility in operation. We
posit that short molecule nanopore sequencing will have
broad applications, in DNA as well as RNA sequencing,
that extend beyond genome copy number quantification.
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